trending Market Intelligence /marketintelligence/en/news-insights/trending/bwjhnyclsvumvry2gbkcxg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Osiris Therapeutics CFO resigns; interim replacement named

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Osiris Therapeutics CFO resigns; interim replacement named

Osiris Therapeutics Inc. said Linda Chang resigned as the company's CFO.

The Columbia, Md.-based maker of regenerative medicine named Joel Rogers interim CFO.

Rogers has been Osiris Therapeutics' corporate controller since October 2017, and was previously corporate controller at industrial equipment maker ARC Group Worldwide, Inc.